ViroGates A/S (OCSE:VIRO) Net Change in Cash : kr-7.26 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is ViroGates A/S Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

ViroGates A/S's Net Change in Cash for the three months ended in Mar. 2024 was kr-3.80 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was kr-7.26 Mil.

ViroGates A/S Net Change in Cash Historical Data

The historical data trend for ViroGates A/S's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViroGates A/S Net Change in Cash Chart

ViroGates A/S Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Change in Cash

Get a 7-Day Free Trial

-18.68

-7.88

-18.67

-4.98

6.15

ViroGates A/S Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-3.42	2.09	-2.13	-3.42	-3.80

ViroGates A/S Net Change in Cash Calculation

ViroGates A/S's Net Change in Cash for the fiscal year that ended in Dec. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-12.179	+	0.012	+	18.315	+	0
	=	6.15

ViroGates A/S's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -3.798 + 0 + 0 + 0

= -3.80

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-7.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViroGates A/S Net Change in Cash Related Terms
Thank you for viewing the detailed overview of ViroGates A/S's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

ViroGates A/S (OCSE:VIRO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ViroGates A/S (OCSE:VIRO) » Definitions » Net Change in Cash

Comparable Companies

OCSE:SMSMED ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA ALGN XSWX:SOON SHSE:688271 ASX:COH LSE:SN. PODD OCSE:DEMANT BRKR BIO

Traded in Other Exchanges

N/A

Address

Banevaenget 13, Birkerod, DNK, DK-3460

Website

https://www.virogates.com

ViroGates A/S is a life science company that develops and sells prognostic products to the healthcare sector. The products are used in hospital emergency services, in particular, to make a clinical decision on hospitalization or discharge of emergency patients. The products can also be used for the prognosis of lifestyle-related diseases such as cardiovascular disease, type 2 diabetes, and cancer. It has developed a product line called suPARnostic to make the suPAR test available as a commercially available test and the ambition is to get the test implemented and used for clinical decision-making.

ViroGates A/S (OCSE:VIRO) Headlines

No Headlines